findmyKOL
Clinical trialNCT07594652RecruitingPhase 4Interventional

Medication Treatment of ADHD in Pediatric Epilepsy

SponsorHugo W. Moser Research Institute at Kennedy Krieger, Inc.Enrollment25ADHD - Attention Deficit Disorder With Hyperactivity
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jay Salpekar, MD

    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Kennedy Krieger Institute

    Baltimore, Maryland, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Methylphenidate
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 May 2026
Primary completion
31 Dec 2030
Completion
31 Dec 2030
Last update posted
29 Jul 2026
Registered enrollment
25
Registry id
NCT07594652
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.